Exposure to U.S. pharmaceutical manufacturers is provided through an exchange‑traded fund that tracks the Dynamic Pharmaceuticals Intellidex Index, which selects and weights companies using quantitative factors such as price momentum, earnings growth, and valuation. The portfolio typically includes ...
1 member of Congress has disclosed 1 trade in 8687 (PJI), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-05-12 | MICHAEL T. MCCAUL | sell | $1M+ |